Hoshiai H - Search Results

1

Relugolix, a novel oral gonadotropin-releasing hormone antagonist, in the treatment of pain symptoms associated with uterine fibroids: a randomized, placebo-controlled, phase 3 study in Japanese women.

Osuga Y, Enya K, Kudou K, Hoshiai H. Osuga Y, et al. Among authors: hoshiai h. Fertil Steril. 2019 Nov;112(5):922-929.e2. doi: 10.1016/j.fertnstert.2019.07.013. Epub 2019 Oct 6. Fertil Steril. 2019. PMID: 31594635 Free article. Clinical Trial.

2

Oral Gonadotropin-Releasing Hormone Antagonist Relugolix Compared With Leuprorelin Injections for Uterine Leiomyomas: A Randomized Controlled Trial.

Osuga Y, Enya K, Kudou K, Tanimoto M, Hoshiai H. Osuga Y, et al. Among authors: hoshiai h. Obstet Gynecol. 2019 Mar;133(3):423-433. doi: 10.1097/AOG.0000000000003141. Obstet Gynecol. 2019. PMID: 30741797 Clinical Trial.

3

Relugolix for oral treatment of uterine leiomyomas: a dose-finding, randomized, controlled trial.

Hoshiai H, Seki Y, Kusumoto T, Kudou K, Tanimoto M. Hoshiai H, et al. BMC Womens Health. 2021 Oct 28;21(1):375. doi: 10.1186/s12905-021-01475-2. BMC Womens Health. 2021. PMID: 34711224 Free PMC article. Clinical Trial.

4

Is endometriosis really associated with pain?

Momoeda M, Taketani Y, Terakawa N, Hoshiai H, Tanaka K, Tsutsumi O, Osuga Y, Maruyama M, Harada T, Obata K, Hayashi K. Momoeda M, et al. Among authors: hoshiai h. Gynecol Obstet Invest. 2002;54 Suppl 1:18-21; discussion 21-3. doi: 10.1159/000066290. Gynecol Obstet Invest. 2002. PMID: 12441656

5

Low-dose oral contraceptive pill for dysmenorrhea associated with endometriosis: a placebo-controlled, double-blind, randomized trial.

Harada T, Momoeda M, Taketani Y, Hoshiai H, Terakawa N. Harada T, et al. Among authors: hoshiai h. Fertil Steril. 2008 Nov;90(5):1583-8. doi: 10.1016/j.fertnstert.2007.08.051. Epub 2007 Dec 27. Fertil Steril. 2008. PMID: 18164001 Free article. Clinical Trial.

6

Evaluation of a low-dose oral contraceptive pill for primary dysmenorrhea: a placebo-controlled, double-blind, randomized trial.

Harada T, Momoeda M, Terakawa N, Taketani Y, Hoshiai H. Harada T, et al. Among authors: hoshiai h. Fertil Steril. 2011 May;95(6):1928-31. doi: 10.1016/j.fertnstert.2011.02.045. Epub 2011 Mar 21. Fertil Steril. 2011. PMID: 21420678 Clinical Trial.

7

Dysmenorrhea in Japanese women.

Osuga Y, Hayashi K, Kobayashi Y, Toyokawa S, Momoeda M, Koga K, Yoshino O, Tsutsumi O, Hoshiai H, Terakawa N, Taketani Y. Osuga Y, et al. Among authors: hoshiai h. Int J Gynaecol Obstet. 2005 Jan;88(1):82-3. doi: 10.1016/j.ijgo.2004.09.004. Int J Gynaecol Obstet. 2005. PMID: 15617718 No abstract available.

8

Feasibility of concurrent cisplatin use during primary and adjuvant chemoradiation therapy: a phase I study in Japanese patients with cancer of the uterine cervix.

Watanabe Y, Nakai H, Shimaoka M, Tobiume T, Tsuji I, Hoshiai H. Watanabe Y, et al. Among authors: hoshiai h. Int J Clin Oncol. 2006 Aug;11(4):309-13. doi: 10.1007/s10147-006-0567-4. Int J Clin Oncol. 2006. PMID: 16937305 Clinical Trial.

9

Deep-vein thrombosis is associated with large uterine fibroids.

Shiota M, Kotani Y, Umemoto M, Tobiume T, Tsuritani M, Shimaoka M, Hoshiai H. Shiota M, et al. Among authors: hoshiai h. Tohoku J Exp Med. 2011 Jun;224(2):87-9. doi: 10.1620/tjem.224.87. Tohoku J Exp Med. 2011. PMID: 21576892 Free article.

10

Evaluation of oral etoposide in combination with cisplatin for patients with recurrent cervical cancer: long-term follow-up results of a Japanese multicenter study.

Watanabe Y, Hoshiai H, Nakanishi T, Kawamura N, Tanaka N, Isaka K, Kamiura S, Ohmichi M, Hatae M, Ochiai K. Watanabe Y, et al. Among authors: hoshiai h. Anticancer Res. 2011 Sep;31(9):3063-7. Anticancer Res. 2011. PMID: 21868560

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

159 results

Search Page